2003年，在严重急性呼吸道综合征流行期间，死亡人数不到800人。
结论在近期有过一次急性冠脉综合征的患者中，利伐沙班降低了包括心血管原因所致死亡、心肌梗死或卒中的复合终点的发生危险。
CONCLUSIONS in patients with a recent acute coronary syndrome, rivaroxaban reduced the risk of the composite end point of death from cardiovascular causes, myocardial infarction, or stroke.
昨日一个热点会议发布，新的研究数据表明与药物洗脱支架(DES)有关的急性冠状动脉综合征死亡率不断增加。
NEW DATA showing increased mortality rates associated with drug eluting stents (DES) in acute coronary syndromes were presented in a Hot Line Session yesterday.
心肺功能停止，急性冠状动脉综合征，中风，肺动脉栓塞，心律不齐是几种常见的死亡原因。
Cardiopulmonary arrest, acute coronary syndrome, stroke, pulmonary embolism, and arrhythmias were the listed causes of deaths (Table 1).
急性冠脉综合征是导致冠心病患者死亡的主要因素。
Acute coronary syndrome are the main factors that cause death of patients with coronary artery disease.
死亡数，急性冠状动脉综合征及肝功能异常在两组相似。
The numbers of deaths, acute coronary syndromes, and abnormal liver-function tests were similar in the two groups.
合并巨细胞病毒感染、细菌感染、急性呼吸窘迫综合征的死亡率显著升高；
The mortality rate of patients who were complicated with cytomegalovirus infection, bacterial infection, acute respiratory distress syndrome (ADRS) significantly increased.
就以SARS（重症急性呼吸综合征）为例。 2003年，这种冠状病毒在全世界造成了恐慌。 在短短一个月内，就有8，100人受到感染，其中774人最终死亡。
Take SARS, or Severe Acute Respiratory Syndrome, the coronavirus that gave the world a scare in 2003 when it infected 8100 people and killed 774 of them in a matter of months.
在对352例急性呼吸窘迫综合征的死亡率都与右心衰竭的发病率队列涉及到高原压力水平在机械通气。
In a cohort of 352 ARDS patients both mortality rate and incidence of right heart failure were related to the level of plateau pressure during mechanical ventilation.
在对352例急性呼吸窘迫综合征的死亡率都与右心衰竭的发病率队列涉及到高原压力水平在机械通气。
In a cohort of 352 ARDS patients both mortality rate and incidence of right heart failure were related to the level of plateau pressure during mechanical ventilation.
应用推荐